| Primary |
| Drug Use For Unknown Indication |
35.0% |
| Product Used For Unknown Indication |
17.9% |
| Blood Triglycerides Increased |
12.4% |
| Blood Cholesterol Increased |
10.9% |
| Hypertension |
5.8% |
| Diabetes Mellitus |
2.8% |
| Hyperlipidaemia |
2.1% |
| Blood Cholesterol |
1.8% |
| Depression |
1.5% |
| Hypertriglyceridaemia |
1.4% |
| High Density Lipoprotein Decreased |
1.1% |
| Blood Pressure |
1.0% |
| Hypothyroidism |
1.0% |
| Vitamin Supplementation |
0.9% |
| Blood Triglycerides |
0.9% |
| Gastrooesophageal Reflux Disease |
0.9% |
| Cardiac Disorder |
0.7% |
| Anxiety |
0.7% |
| Type 2 Diabetes Mellitus |
0.7% |
| Dyslipidaemia |
0.6% |
|
| Myalgia |
14.8% |
| Blood Creatinine Increased |
7.7% |
| Muscle Spasms |
6.6% |
| Blood Triglycerides Increased |
5.8% |
| Nausea |
5.7% |
| Pain In Extremity |
5.7% |
| Rhabdomyolysis |
5.4% |
| Drug Ineffective |
5.2% |
| Pancreatitis |
5.2% |
| Rash |
4.6% |
| High Density Lipoprotein Decreased |
4.3% |
| Weight Decreased |
4.3% |
| Hepatic Enzyme Increased |
3.9% |
| Pain |
3.6% |
| Liver Function Test Abnormal |
3.5% |
| Headache |
3.0% |
| Urticaria |
3.0% |
| Low Density Lipoprotein Increased |
2.7% |
| Muscular Weakness |
2.7% |
| Myocardial Infarction |
2.5% |
|
| Secondary |
| Blood Cholesterol Increased |
16.7% |
| Drug Use For Unknown Indication |
15.6% |
| Product Used For Unknown Indication |
12.9% |
| Blood Triglycerides Increased |
12.5% |
| Diabetes Mellitus |
6.2% |
| Hypertension |
6.1% |
| Depression |
5.7% |
| High Density Lipoprotein Decreased |
3.1% |
| Hyperlipidaemia |
2.8% |
| Low Density Lipoprotein Increased |
2.5% |
| Blood Cholesterol |
2.4% |
| Hypertriglyceridaemia |
2.2% |
| Pain |
1.8% |
| Tachyarrhythmia |
1.8% |
| Dyslipidaemia |
1.4% |
| Hypercholesterolaemia |
1.4% |
| Blood Triglycerides |
1.3% |
| Anxiety |
1.3% |
| Blood Pressure |
1.2% |
| Hypothyroidism |
1.0% |
|
| Myalgia |
13.7% |
| Rhabdomyolysis |
8.1% |
| Drug Hypersensitivity |
7.8% |
| Pain In Extremity |
6.8% |
| Weight Decreased |
6.5% |
| Weight Increased |
6.2% |
| Muscle Spasms |
5.9% |
| Myocardial Infarction |
5.5% |
| Blood Triglycerides Increased |
4.6% |
| Arthralgia |
3.6% |
| Pancreatitis |
3.6% |
| Renal Failure Acute |
3.6% |
| Urticaria |
3.6% |
| Hepatic Enzyme Increased |
3.3% |
| Pain |
3.3% |
| Drug Ineffective |
2.9% |
| Interstitial Lung Disease |
2.9% |
| Vomiting |
2.9% |
| Headache |
2.6% |
| Liver Function Test Abnormal |
2.6% |
|
| Concomitant |
| Product Used For Unknown Indication |
27.7% |
| Drug Use For Unknown Indication |
18.5% |
| Blood Cholesterol Increased |
7.2% |
| Hypertension |
7.1% |
| Diabetes Mellitus |
6.8% |
| Type 2 Diabetes Mellitus |
4.2% |
| Depression |
3.8% |
| Pain |
3.3% |
| Blood Triglycerides Increased |
2.5% |
| Gastrooesophageal Reflux Disease |
2.3% |
| Anxiety |
2.2% |
| Blood Cholesterol |
2.2% |
| Cardiac Disorder |
1.8% |
| Smoking Cessation Therapy |
1.7% |
| Hiv Infection |
1.5% |
| Hyperlipidaemia |
1.5% |
| Atrial Fibrillation |
1.4% |
| Bipolar Disorder |
1.4% |
| Rheumatoid Arthritis |
1.3% |
| Insomnia |
1.3% |
|
| Weight Decreased |
13.9% |
| Vomiting |
9.8% |
| Weight Increased |
9.2% |
| Myocardial Infarction |
8.3% |
| Flushing |
7.3% |
| Type 2 Diabetes Mellitus |
5.0% |
| Drug Ineffective |
4.8% |
| Nausea |
4.8% |
| Pancreatitis |
4.7% |
| Pruritus |
4.2% |
| Pain |
3.6% |
| Blood Glucose Increased |
3.4% |
| Pain In Extremity |
3.1% |
| Urinary Tract Infection |
2.8% |
| Vision Blurred |
2.7% |
| Death |
2.7% |
| Rash |
2.6% |
| Paraesthesia |
2.5% |
| Somnolence |
2.4% |
| Transient Ischaemic Attack |
2.3% |
|
| Interacting |
| Product Used For Unknown Indication |
30.7% |
| Diabetes Mellitus |
16.3% |
| Depression |
14.5% |
| Tachyarrhythmia |
7.2% |
| Blood Cholesterol Increased |
5.4% |
| Dyslipidaemia |
3.6% |
| Blood Cholesterol |
3.0% |
| High Density Lipoprotein Decreased |
3.0% |
| Blood Pressure Abnormal |
2.4% |
| Blood Triglycerides Increased |
2.4% |
| Hyperlipidaemia |
1.8% |
| Anxiety |
1.2% |
| Arthritis |
1.2% |
| Hypercholesterolaemia |
1.2% |
| Mineral Supplementation |
1.2% |
| Obstructive Airways Disorder |
1.2% |
| Rheumatoid Arthritis |
1.2% |
| Smoking Cessation Therapy |
1.2% |
| Analgesic Therapy |
0.6% |
| Angina Pectoris |
0.6% |
|
| Myocardial Infarction |
24.0% |
| Drug Interaction |
16.0% |
| Overdose |
8.0% |
| Rhabdomyolysis |
8.0% |
| Agranulocytosis |
4.0% |
| Drug Ineffective |
4.0% |
| Emotional Distress |
4.0% |
| Haemarthrosis |
4.0% |
| Hallucination |
4.0% |
| High Density Lipoprotein Decreased |
4.0% |
| Nervousness |
4.0% |
| Renal Impairment |
4.0% |
| Toxicity To Various Agents |
4.0% |
| Urine Colour Abnormal |
4.0% |
| Urticaria |
4.0% |
|
